By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Clarient, Inc. 

31 Columbia

Aliso Viejo  California  92656  U.S.A.
Phone: 949-425-5700 Fax: 949-425-5701


Company News
Definiens Signs Agreement With Clarient, Inc. To Offer Validated Solutions For Routine Clinical Pathology Testing 2/3/2014 8:16:37 AM
bioMerieux, Inc.'s THxID®-BRAF Test For Detection Of 2 BRAF Mutations V600E And V600K In Late-Stage Metastatic Melanoma Adopted By Clarient, Inc., A GE Healthcare Company 1/29/2014 10:49:42 AM
Clarient, Inc., a GE Healthcare Company, Introduces First Lab Developed Test to Assess Multiple Proteins at Single-Cell Level 7/10/2013 9:25:30 AM
Arno Therapeutics to Collaborate With Clarient, Inc. for Development of Diagnostic Test 5/10/2013 9:33:45 AM
Clarient, Inc. and ACORN Research LLC Announce a Collaboration to Standardize Testing of Most Common Cancers 12/9/2011 6:38:30 AM
Clarient, Inc. Joins the HistoRx, Inc. Clinical Trials Network: First Commercial Lab to Provide Aqua(R) Technology for Clinical Trials 10/24/2011 2:18:16 PM
Biocept, Inc. and Clarient, Inc. Announce Collaboration on First Test for Circulating Tumor Cells and HER2 Status in Breast Cancer Patients 8/25/2011 11:07:39 AM
CombiMatrix Corporation (CBMX) Partners With Clarient, Inc. to Commercialize CombiMatrix Genomic Profile Tests for Cancer 4/11/2011 9:54:27 AM
Safeguard Scientifics (SFE) Realizes $144 Million in Net Proceeds from Completion of Tender Offer for Clarient, Inc. by GE Healthcare 12/17/2010 7:39:52 AM
Clarient, Inc. Launches Insight(R) Dx Mammostrat(R) Breast Cancer Recurrence Test 12/9/2010 7:17:13 AM